Another Milestone for PHA Mission to Promote Awareness
With this third issue of Advances in Pulmonary Hypertension in 2007, I must first recognize the enormous success of the Pulmonary Hypertension Resource Network Symposium held in Crystal City, Virginia this October. Attendance was a record 400+ (up from 60 in 2003), and the representation was far-reaching, with attendees and participants from Oregon to Washington, DC, and Canada to Texas. This clearly reflects the tremendous interest in this growing field and speaks to the success of PHA in its mission to promote pulmonary hypertension awareness.
Associate Editor Erika Berman Rosenzweig, MD, has taken the role of Lead Editor of this issue and with Editorial Board member Kristin Highland, MD, has put together a comprehensive review of pulmonary arterial hypertension (PAH) related to congenital heart disease (CHD), with three key pieces focused on CHD. Dr Ingram Schulze-Neick provides an overview of pulmonary vascular disease in CHD, while Dr Michael Landzberg covers emerging medical therapies, and Drs Konstantinos Dimopoulos and Michael Gatzoulis teach us about how to evaluate operability in adults with CHD, as well as the role of pretreatment with targeted PAH therapy. A specialist roundtable discussion is a highlight of this issue, as it covers the practical aspects of treating patients with CHD and associated PAH. Dr Berman Rosenzweig and her contributors are to be congratulated for their efforts in producing such a wonderful issue of Advances.
Ronald J. Oudiz, MD
Editor-in-Chief
Guest Editor’s Commentary
Focusing on Pulmonary Arterial
Hypertension in Adults with
Congenital Heart Disease
This issue of Advances in Pulmonary Hypertension focuses on the
growing population of adults with congenital heart disease (CHD)
and associated pulmonary arterial hypertension (PAH). Although
progress in diagnostics and surgical intervention has dramatically
decreased the incidence of classic Eisenmenger syndrome in the
Western world, these advances have led to a rapidly growing
number of adults with CHD and associated PAH.
In this journal edition, the authors highlight some of the
considerations and challenges specific to the adult with PAH associated with CHD.
Admittedly, there are still more questions than answers for these patients; the
authors hope to bring to light some of the important issues that require further
study.
Erika Berman Rosenzweig, MD, Guest Editor
Assistant Professor of Pediatrics (in Medicine)
Division of Pediatric Cardiology
Columbia University College of Physicians and Surgeons
New York, New York
Articles
Advances in Pulmonary Hypertension,
Autumn 2007, Vol. 6, No. 3
Editor-in-Chief Richard Channick, MD
Professor of Clinical Medicine
Pulmonary and Critical Care Division
University of California, San Diego Medical Center
San Diego, California
Immediate Past Editor Ronald J. Oudiz, MD
Associate Professor of Medicine
The David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Editor-in-Chief Elect Erika Berman Rosenzweig, MD
Director, Pulmonary
Hypertension Center, Columbia University Medical Center Associate
Professor of Clinical Pediatrics (in Medicine)
Associate Editors
Kristin Highland, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University Of Carolina
Francisco Soto, MD, MS
Director, Pulmonary Hypertension Program
Pulmonary and Critical Care Medicine
Medical College of Wisconsin
Todd Bull, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Robert Schilz, DO, PhD
Medical Director of Lung
Transplantation and Pulmonary Vascular Disease
University Hospital of Cleveland
Case Western Reserve University
Cleveland, Ohio
Publisher
Pulmonary Hypertension Association
Carl Hicks, Board Chair
Rino Aldrighetti, President
Sherrie Borden, Vice President, Medical and Patient Education
Publishing Staff Managing Editor
Deborah L. McBride
McBride Strategic Services
mcbridedeb@aol.com
P: 773-348-5455
C: 312-307-5455
Design Director
Michael McClain
Advances in Pulmonary Hypertension is circulated to
cardiologists, pulmonologists, rheumatologists and other selected
physicians by the Pulmonary Hypertension Association. The contents of the articles are independently determined by the Editor
and the Editorial Advisory Board.
Editorial Mission Advances in Pulmonary Hypertension is committed
to help physicians in their clinical decision
making by informing them of important
trends affecting their practice. Analyzing the
impact of new findings and covering current
information in the peer-reviewed literature,
Advances in Pulmonary Hypertension is published
four times a year. Advances in Pulmonary
Hypertension is the official journal
of the Pulmonary Hypertension Association.
Each article in this journal has been reviewed
and approved by members of the Editorial
Advisory Board.
Editorial Board
Charles Burger, MD
Medical Director, PH Clinic
Mayo Clinic
Jacksonville, FL
Karen Fagan, M.D. Chief, Division of Pulmonary and Critical Care Medicine University of South Alabama
Eli Gabbay, MD
Lung Transplant Unit
Royal Perth Hospital
Nick Kim, M.D.
Associate Clinical Professor of Medicine
University of California San Diego
Deborah Jo Levine, M.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX
Omar Minai, MD
Dept of Pulmonary, Allergy and Critical Care Medicine
Myung Park, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Fernando Torres, MD Director Pulmonary Hypertension Clinic
UTSW Medical Center Dallas
University Hospital
Glenna Traiger, RN, MSN
Pulmonary & Critical Care
Pulmonary Hypertension CNS
University of California Los Angeles
Los Angeles, CA
R. James White, MD, PhD
Assistant Professor of Medicine, Pharmacology & Physiology
University of Rochester, Division of Pulmonary and CCM
Roham Zamanian, MD
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
With this third issue of Advances in Pulmonary Hypertension in 2007, I must first recognize the enormous success of the Pulmonary Hypertension Resource Network Symposium held in Crystal City, Virginia this October. Attendance was a record 400+ (up from 60 in 2003), and the representation was far-reaching, with attendees and participants from Oregon to Washington, DC, and Canada to Texas. This clearly reflects the tremendous interest in this growing field and speaks to the success of PHA in its mission to promote pulmonary hypertension awareness.
